Cargando…

The Role of Sclerostin in Rheumatic Diseases: A Review

Systemic connective tissue disorders constitute a heterogenous group of autoimmune diseases with the potential to affect a range of organs. Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune inflammatory disease affecting the joints. Systemic lupus erythematosus (SLE) may manifest with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaśkiewicz, Łukasz, Chmielewski, Grzegorz, Kuna, Jakub, Stompór, Tomasz, Krajewska-Włodarczyk, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573925/ https://www.ncbi.nlm.nih.gov/pubmed/37834893 http://dx.doi.org/10.3390/jcm12196248

Ejemplares similares

Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome
por: Kuna, Jakub, et al.
Publicado: (2022)

Fatigue in Inflammatory Joint Diseases
por: Chmielewski, Grzegorz, et al.
Publicado: (2023)

Fatal Acute Heart Failure in the Course of Macrophage Activation Syndrome: Case Report and Literature Review
por: Kuna, Jakub, et al.
Publicado: (2022)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
por: Sanabria-de la Torre, Raquel, et al.
Publicado: (2022)

Sclerostin and occlusion: A brief review
por: Bansal, Pankaj, et al.
Publicado: (2015)

Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2019)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology
por: Stompór, Tomasz, et al.
Publicado: (2023)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Monostotic Paget’s disease of bone – literature review and case report
por: Wysiński, Piotr, et al.
Publicado: (2019)

Aseptic Abscess Syndrome in Rheumatoid Arthritis Patient
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2022)

The Role of Chronic Fatigue in Patients with Crohn’s Disease
por: Włodarczyk, Marcin, et al.
Publicado: (2023)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

Drug discovery of sclerostin inhibitors
por: Yu, Sifan, et al.
Publicado: (2022)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

The role of sclerostin and dickkopf-1 in oral tissues – A review from the perspective of the dental disciplines
por: Samiei, Mohammad, et al.
Publicado: (2019)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Sclerostin: Current Knowledge and Future Perspectives
por: Moester, M. J. C., et al.
Publicado: (2010)

Sclerostin: From Molecule to Clinical Biomarker
por: Omran, Ahmed, et al.
Publicado: (2022)

Positive and Negative Regulators of Sclerostin Expression
por: Iwamoto, Rina, et al.
Publicado: (2022)

Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
por: Cejka, Daniel
Publicado: (2021)

The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up
por: Kern, Adam, et al.
Publicado: (2021)

Usefulness of Ultrasound Examination in the Assessment of the Nail Apparatus in Psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2022)

Obesity and Bone Loss at Menopause: The Role of Sclerostin
por: Marzullo, Paolo, et al.
Publicado: (2021)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

Sclerostin: clinical insights in muscle–bone crosstalk
por: Moretti, Antimo, et al.
Publicado: (2023)

Sclerostin Modulation Holds Promise for Dental Indications
por: Hassan, Mohamed G., et al.
Publicado: (2018)

Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
por: Vasiliadis, Elias S., et al.
Publicado: (2021)

Role of ultrasonography in the diagnosis of rheumatic diseases in light of ACR/EULAR guidelines
por: Płaza, Mateusz, et al.
Publicado: (2016)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Osteoblast Role in Rheumatic Diseases
por: Corrado, Addolorata, et al.
Publicado: (2017)

The Role of Aquaporin 5 (AQP5) in Lung Adenocarcinoma: A Review Article
por: Jaskiewicz, Lukasz, et al.
Publicado: (2023)

Copper and Zinc Particles as Regulators of Cardiovascular System Function—A Review
por: Kitala, Klaudia, et al.
Publicado: (2023)

Role of Stem Cells in Pathophysiology and Therapy of Spondyloarthropathies—New Therapeutic Possibilities?
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017)

Importance of Sclerostin as Bone-Muscle Mediator Crosstalk
por: Aryana, I Gusti Putu Suka, et al.
Publicado: (2022)

Sclerostin's role in bone's adaptive response to mechanical loading
por: Galea, Gabriel L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vd02f9p32c24md4sk67ga3irgf